XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Lessor Leases | 3 Months Ended
--- | ---
Mar. 31, 2025
Leases [Abstract] |
Lessor Leases | Lessor Leases Sales-Type Leases The Company enters into non-cancelable sales-type lease arrangements with the leases varying in length from one to ten years. The Company optimizes cash flows by selling a majority of its sales-type leases, other than those relating to U.S. government hospitals and SaaS and Expert Services products, including Central Pharmacy Dispensing Service and IV C ompounding Service, to third-party leasing finance companies on a non-recourse basis. The Company generally has no obligation to the leasing company once the lease has been sold. The following table presents the Company’s income recognized from sales-type leases:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2025 |  | 2024
|  |  |  |  | (In thousands)
Sales-type lease revenues |  |  |  |  | $ | 5,818 |  |  | $ | 7,036 |
Cost of sales-type lease revenues |  |  |  |  | (2,937) |  |  | (4,187) |
Selling profit on sales-type lease revenues |  |  |  |  | $ | 2,881 |  |  | $ | 2,849 |
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components:
| March 31, 2025 |  | December 31, 2024
| (In thousands)
Net minimum lease payments to be received | $ | 77,528 |  |  | $ | 77,976 |
Less: Unearned interest income portion | (12,393) |  |  | (12,757) |
Net investment in sales-type leases | 65,135 |  |  | 65,219 |
Less: Current portion (1) | (12,601) |  |  | (12,475) |
Long-term investment in sales-type leases, net | $ | 52,534 |  |  | $ | 52,744 |
_________________________________________________ (1) The current portion of the net investment in sales-type leases is included in other current assets in the Condensed Consolidated Balance Sheets. The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value. The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Condensed Consolidated Balance Sheets was as follows:
| March 31, 2025
| (In thousands)
Remaining nine months of 2025 | $ | 12,156 |
2026 | 14,608 |
2027 | 13,145 |
2028 | 12,049 |
2029 | 9,441 |
Thereafter | 16,129 |
Total future minimum sales-type lease payments | 77,528 |
Present value adjustment | (12,393) |
Total net investment in sales-type leases | $ | 65,135 |

X
- References No definition available. + Details
Name: | us-gaap_LeasesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of lessor's sales-type leases. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-30/tableOfContent + Details
Name: | us-gaap_LessorSalesTypeLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration